These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8054317)

  • 21. Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats.
    McDaid J; Tedford CE; Mackie AR; Dallimore JE; Mickiewicz AL; Shen F; Angle JM; Napier TC
    Drug Alcohol Depend; 2007 Jan; 86(1):55-66. PubMed ID: 16762517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.
    Nikaido T; Akiyama M; Moriya T; Shibata S
    Mol Pharmacol; 2001 Apr; 59(4):894-900. PubMed ID: 11259635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice.
    Kuribara H; Uchihashi Y
    J Pharm Pharmacol; 1993 Dec; 45(12):1042-5. PubMed ID: 7908972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine.
    Ujike H; Akiyama K; Otsuki S
    Psychopharmacology (Berl); 1990; 102(4):459-64. PubMed ID: 2151400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
    Tidey JW; Bergman J
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent supersensitivity of sigma receptors develops during repeated methamphetamine treatment.
    Ujike H; Okumura K; Zushi Y; Akiyama K; Otsuki S
    Eur J Pharmacol; 1992 Feb; 211(3):323-8. PubMed ID: 1352252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sigma (sigma) antagonist BMY 14802 prevents methamphetamine-induced sensitization.
    Ujike H; Kanzaki A; Okumura K; Akiyama K; Otsuki S
    Life Sci; 1992; 50(16):PL129-34. PubMed ID: 1313134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The analeptic effect of methamphetamine in pentobarbital-narcotized rats is mediated via a dopaminergic-cholinergic mechanism.
    Horita A; Carino MA; Ukai Y
    J Pharmacol Exp Ther; 1994 Jan; 268(1):311-8. PubMed ID: 7905529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
    Reeves R; Thiruchelvam M; Cory-Slechta DA
    Brain Res; 2004 May; 1008(2):155-67. PubMed ID: 15145752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
    Ota M; Ogawa S; Kato K; Wakabayashi C; Kunugi H
    Psychiatry Res; 2015 Apr; 232(1):92-7. PubMed ID: 25703679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide.
    Landa L; Jurajda M; Sulcova A
    Neuro Endocrinol Lett; 2012; 33(4):446-52. PubMed ID: 22936253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of sigma 1 receptors in methamphetamine-induced behavioral sensitization in rats.
    Takahashi S; Miwa T; Horikomi K
    Neurosci Lett; 2000 Jul; 289(1):21-4. PubMed ID: 10899399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alteration of neuronal activities following repeated administration of stimulants].
    Amano T; Matsubayashi H; Sasa M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2002 Feb; 37(1):31-40. PubMed ID: 11915303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of SCH 23390 into the medial prefrontal cortex blocks the expression of MDMA-induced behavioral sensitization in rats: an effect mediated by 5-HT2C receptor stimulation and not by D1 receptor blockade.
    Ramos M; Goñi-Allo B; Aguirre N
    Neuropsychopharmacology; 2005 Dec; 30(12):2180-91. PubMed ID: 15841107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased occupation of D1 and D2 dopamine receptors accompanies cocaine-induced behavioral sensitization.
    Burger LY; Martin-Iverson MT
    Brain Res; 1994 Mar; 639(2):228-32. PubMed ID: 8205476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice.
    Rahmadi M; Mori T; Kanazawa M; Kubota H; Shibasaki M; Suzuki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Apr; 33(2):49-56. PubMed ID: 25069239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of matrix metalloproteinase and tissue inhibitor of MMP in methamphetamine-induced behavioral sensitization and reward: implications for dopamine receptor down-regulation and dopamine release.
    Mizoguchi H; Yamada K; Mouri A; Niwa M; Mizuno T; Noda Y; Nitta A; Itohara S; Banno Y; Nabeshima T
    J Neurochem; 2007 Sep; 102(5):1548-1560. PubMed ID: 17472698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.